I thought i would complile the 4C's from the last few years to see how things are tracking for RHT.
Financials are looking pretty solid, really looking forward to the next 4C, due in the next few weeks.
Apologies for the file being so big, first time posting like this.
Appendix 4C RHT RHT RHT RHT RHT RHT RHT RHT RHT RHT RHT RHT RHT RHT RHT Quarterly report for entities subject to Listing Rule 4.7B Financial Year ended :- 2016 / 2017 2017 / 2018 2018 / 2019 Quarter ended :- 30/09/2016 31/12/2016 31/03/2017 30/06/2017 2016/2017 30/09/2017 31/12/2017 31/03/2018 30/06/2018 2017/2018 30/09/2018 31/12/2018 31/03/2019 30/06/2019 2018/2019 Consolidated statement of cash flows 1st quarter $A’000 2nd quarter $A’000 3rd quarter $A’000 4th quarter $A’000 year to date $A’000 1st quarter $A’000 2nd quarter $A’000 3rd quarter $A’000 4th quarter $A’000 year to date $A’000 1st quarter $A’000 2nd quarter $A’000 3rd quarter $A’000 4th quarter $A’000 year to date $A’000 % Change 4C reporting date 28/10/2016 31/01/2017 28/04/2017 31/07/2017 31/10/2017 31/01/2018 23/04/2018 23/07/2018 29/10/2018 21/01/2019 16/04/2019 Share Price at end of 4C report date $0.020 $0.022 $0.023 $0.023 $0.027 $0.099 $0.135 1 Cash flows from operating activities 1.1 Receipts from customers - actual 324 775 661 531 2291 608 563 634 847 2652 680 907 961 840 3388 28% Receipts from customers - estimated 540 790 814 589 681 712 654 2636 635 730 810 840 3015 1.2 Payments for (a) research and development - actual -59 -277 -136 -284 -756 -199 -58 -187 -139 -583 -110 -169 -147 -168 -594 2% (a) research and development - estimated -181 -220 -263 -228 -105 -110 -148 -591 -59 -100 -153 -168 -480 (b) product manufacturing and operating costs 0 0 0 (c) advertising and marketing - actual -150 -168 -162 -154 -634 -164 -200 -125 -141 -630 -55 -86 -59 -53 -253 -60% (c) advertising and marketing - estimated -185 -120 -151 -130 -114 -137 -68 -449 -41 -61 -84 -53 -239 (d) leased assets 0 0 0 (e) staff costs - actual -406 -395 -340 -391 -1532 -393 -469 -360 -387 -1609 -338 -363 -350 -357 -1408 -12% (e) staff costs - estimated -409 -350 -425 -378 -470 -350 -355 -1553 -348 -339 -351 -357 -1395 (f) administration and corporate costs - actual -194 -15 -149 -101 -459 -150 -70 -89 -136 -445 -133 -88 -92 -90 -403 -9% (f) administration and corporate costs - estimated -223 -210 -170 -206 -191 -70 -60 -527 -144 -136 -89 -90 -459 1.3 Dividends received (see note 3) 0 0 0 1.4 Interest received 13 5 10 28 4 3 3 5 15 6 5 6 17 1.5 Interest and other costs of finance paid 0 0 0 1.6 Income taxes paid 0 0 0 1.7 Government grants and tax incentives 20 20 452 452 328 328 1.8 Other (provide details if material) 315 315 0 0 1.9 Net cash from / (used in) operating activities -485 -67 -121 -54 -727 -294 -231 328 49 -148 50 534 319 172 1075 -826% 2 Cash flows from investing activities 2.1 Payments to acquire: (a) property, plant and equipment -20 0 0 -13 -33 -13 -6 0 -1 -20 -1 0 -2 -3 (b) businesses (see item 10) 0 0 0 (c) investments 0 0 0 (d) intellectual property 0 0 0 (e) other non-current assets 0 0 0 2.2 Proceeds from disposal of: 0 0 0 (a) property, plant and equipment 0 0 0 (b) businesses (see item 10) 0 0 0 (c) investments 0 0 0 (d) intellectual property 0 0 0 (e) other non-current assets 0 0 0 2.3 Cash flows from loans to other entities 0 0 0 2.4 Dividends received (see note 3) 0 0 0 2.5 Other (provide details if material) -27 -27 0 0 2.6 Net cash from / (used in) investing activities -20 0 0 -40 -60 -13 -6 0 -1 -20 -1 0 -2 0 -3 3 Cash flows from financing activities 3.1 Proceeds from issues of shares 3.2 Proceeds from issue of convertible notes 3.3 Proceeds from exercise of share options 3.4 Transaction costs related to issues of shares, convertible notes or options 3.5 Proceeds from borrowings 3.6 Repayment of borrowings 3.7 Transaction costs related to loans and borrowings 3.8 Dividends paid 3.9 Other (provide details if material) 3.1 Net cash from / (used in) financing activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 Net increase / (decrease) in cash and cash equivalents for the period 4.1 Cash and cash equivalents at beginning of quarter/year to date 2512 2042 1920 1863 1685 1363 1116 1477 1549 1609 2144 2468 4.2 Net cash from / (used in) operating activities (item 1.9 above) -485 -67 -121 -54 -727 -294 -231 328 49 -148 50 534 319 172 1075 4.3 Net cash from / (used in) investing activities (item 2.6 above) -20 0 0 -40 -60 -13 -6 0 -1 -20 -1 0 -2 0 -3 4.4 Net cash from / (used in) financing activities (item 3.10 above) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.5 Effect of movement in exchange rates on cash held 35 -55 64 -84 -40 -15 -10 33 24 32 11 1 7 19 4.6 Cash and cash equivalents at end of quarter 2042 1920 1863 1685 1363 1116 1477 1549 1549 1609 2144 2468 2640 5 Reconciliation of cash and cash equivalents at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts 5.1 Bank balances 2042 1920 1863 1685 1685 1363 1116 1477 1549 1549 1609 2144 2468 0 5.2 Call deposits 5.3 Bank overdrafts 5.4 Other (provide details) 5.5 Cash and cash equivalents at end of quarter (should equal item 4.6 above) 2042 1920 1863 1685 1685 1363 1116 1477 1549 1549 1609 2144 2468 2640 2640 6 Payments to directors of the entity and their associates 6.1 Aggregate amount of payments to these parties included in item 1.2 35 39 45 45 164 35 35 35 35 140 60 55 70 185 6.2 Aggregate amount of cash flow from loans to these parties included in item 2.3 6.3 Explanation necessary to understand the transactions included in items 6.1 and 6.2 Directors Fee Directors Fee Directors Fee Directors Fee Directors Fee Directors Fee Directors Fee Directors Fee Directors Fee / Consultancy Fee Directors Fee / Consultancy Fee Directors Fee / Consultancy Fee 7 Payments to related entities of the entity and their associates Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter Current quarter $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 $A'000 7.1 Aggregate amount of payments to these parties included in item 1.2 7.2 Aggregate amount of cash flow from loans to these parties included in item 2.3 7.3 Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2 8 Financing facilities available Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Total facility amount at quarter end Add notes as necessary for an understanding of the position 8.1 Loan facilities 8.2 Credit standby arrangements 8.3 Other (please specify) 8.4 Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well. 9 Estimated cash outflows for next quarter 9.1 Research and development -181 -220 -263 -228 -892 -105 -110 -148 -59 -422 -100 -153 -168 -421 9.2 Product manufacturing and operating costs 0 0 0 9.3 Advertising and marketing -185 -120 -151 -130 -586 -114 -137 -68 -41 -360 -61 -84 -53 -198 9.4 Leased assets 0 0 0 9.5 Staff costs -409 -350 -425 -378 -1562 -470 -350 -355 -348 -1523 -339 -351 -357 -1047 9.6 Administration and corporate costs -223 -210 -170 -206 -809 -191 -70 -60 -144 -465 -136 -89 -90 -315 9.7 Other (provide details if material) 0 0 0 9.8 estimated cash outflows -998 -900 -1009 -942 -3849 -880 -667 -631 -592 -2770 -636 -677 -668 0 -1981 9.9 estimated receivables 540 790 814 589 2733 681 712 654 635 2682 730 810 840 2380 9.1 Total estimated cash outflows -458 -110 -195 -353 -1116 -199 45 23 43 -88 94 133 172 0 399 10 Acquisitions and disposals of business entities Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions Acquisitions (items 2.1(b) and 2.2(b) above) 10.1 Name of entity 10.2 Place of incorporation or registration 10.3 Consideration for acquisition or disposal 10.4 Total net assets 10.5 Nature of business
- Forums
- ASX - By Stock
- RHT
- Ann: Appendix 4C - quarterly
RHT
resonance health limited
Add to My Watchlist
0.00%
!
4.0¢

Ann: Appendix 4C - quarterly, page-57
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.38M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 460 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 75743 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 460 | 0.040 |
2 | 100000 | 0.039 |
4 | 1621198 | 0.038 |
1 | 200000 | 0.037 |
3 | 167501 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 75743 | 2 |
0.049 | 128357 | 2 |
0.050 | 42423 | 3 |
0.055 | 60000 | 1 |
0.060 | 66666 | 1 |
Last trade - 16.21pm 03/07/2025 (20 minute delay) ? |
Featured News
RHT (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Matthew Kowal / Andy Burger, CCO / Head of E-Commerce
Matthew Kowal / Andy Burger
CCO / Head of E-Commerce
SPONSORED BY The Market Online